Summus Taps Healthcare Veteran to Tackle Soaring Complex Care Costs

NEW YORK, NY – May 28, 2026 – In a significant move to address the spiraling costs of complex healthcare, physician-led platform Summus has appointed veteran executive Michael P. Tilton as its new Chief Commercial Officer. The appointment comes as employers and health plans grapple with projected healthcare cost increases of up to 9% annually, intensifying the search for effective solutions to manage high-cost medical cases.

Tilton, a seasoned leader with decades of experience at industry giants like Humana and Blue Cross Blue Shield, is tasked with leading Summus's go-to-market strategy. His role will be pivotal in scaling the company's unique model, which places physicians at the center of a patient's journey, to a wider audience of self-insured employers and health plans desperate to bend the cost curve without sacrificing quality of care.

The Mounting Pressure of a $4 Trillion Problem

The backdrop for Tilton's appointment is a healthcare landscape under immense strain. Industry reports from firms like Mercer project that the average cost of employer-sponsored health benefits is set to climb by as much as 9% in the coming year, the steepest increase in over a decade. This surge is driven by a confluence of factors, including the high price of new specialty drugs, increased utilization of services post-pandemic, and the rising prevalence of chronic and complex conditions.

For employers and health plans, the financial burden is becoming unsustainable. A disproportionate amount of this spending is concentrated on a small percentage of members with complex medical needs—those battling cancer, rare diseases, or multiple chronic conditions. This segment of the population navigates a fragmented and often bewildering system of specialists, leading to delayed diagnoses, suboptimal treatment plans, and soaring costs. The challenge is not just financial; it's about providing meaningful support to individuals during their most vulnerable moments. It is this high-stakes environment that has created a fertile ground for innovative solutions like the one Summus champions.

A Commercial Heavyweight for a Clinical Mission

Summus's decision to bring Tilton aboard signals a clear intent to accelerate its commercial growth and solidify its position as a key player in the complex care management space. His resume reads like a who's who of American healthcare. Most recently at Humana, he served as Senior Vice President of Specialty and Retiree Solutions, where he was responsible for a massive portfolio of businesses representing over $12.7 billion in annual revenue.

Prior to that, as General Manager for Blue Cross Blue Shield of Arizona's Commercial Segment, he oversaw a $2 billion revenue stream and was credited with significantly improving profitability for administrative services only (ASO) clients—a key target market for Summus. His career also includes senior roles at UnitedHealth Group, Cigna, and GlaxoSmithKline, giving him a panoramic view of the payer, provider, and pharmaceutical landscape.

"We're thrilled to welcome Mike to the Summus team at a significant moment in healthcare and for our company," said Julian Flannery, Founder and CEO of Summus, in a statement. "Mike's deep experience in healthcare and across the largest health plans positions him to meaningfully impact existing and future partnerships across health plans, benefits consultants, and self-insured employers at this important growth inflection point for Summus." Flannery emphasized that Tilton's leadership will be "instrumental as we scale our platform and continue to advance our vision of one platform, every health journey."

Differentiating in a Crowded Digital Health Market

In a digital health market saturated with telehealth and wellness apps, Summus has carved out a distinct niche by focusing on what it calls the "only physician-led, multi-specialty platform purpose-built for the highest-cost, most complex members." This isn't about replacing a primary care physician with a video call; it's about providing rapid access to a curated network of over 5,100 elite specialists from top-tier medical institutions.

The company’s model provides longitudinal support, meaning it stays with the member throughout their entire care journey. This can range from getting a second opinion on a complex cancer diagnosis to navigating treatment options for a rare pediatric condition. By putting a trusted physician at the center of these decisions, Summus aims to shorten diagnostic journeys from months to days, prevent unnecessary procedures, and ensure members are on the most effective and cost-efficient treatment path. The platform offers end-to-end programs in high-cost areas like cancer, musculoskeletal, gastrointestinal, brain, and women's health.

This clinical-first approach is precisely what attracted Tilton to the role. "Summus has built something genuinely different in healthcare: a physician-led platform that meets members at every step of their care journey, from a first question to the most complex care decisions," Tilton stated. "Employers and health plans are under enormous pressure to manage the highest-cost, most complex members without compromising member experience. The Summus model directly addresses that challenge, and I'm excited to help bring it to more health plans and employer partners and members."

Scaling to Meet a Critical Market Need

This strategic executive hire is backed by significant investor confidence. Summus has raised over $91 million in funding, including a recent Series C round in March 2026, providing the capital necessary for an aggressive expansion. The combination of fresh funding and Tilton's commercial prowess positions Summus to capitalize on the urgent market demand.

The company is betting that as employers and health plans move beyond simple cost-shifting to employees, they will increasingly seek out strategic partners that can deliver demonstrable improvements in both health outcomes and financial performance. By deploying a veteran commercial leader to scale a platform built on clinical excellence, Summus is making a calculated play to become the go-to solution for the most challenging and expensive problems in American healthcare. Tilton's leadership will be critical in translating Summus's unique clinical model into the language of ROI and value that resonates with C-suites and benefits leaders nationwide, potentially reshaping how complex care is managed for millions.